國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 912576      Online Users : 1210
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Books/Book Section [1/1]
    Conference Papers/Meeting Abstract [16/27]
    Periodical Articles [65/66]

    Community Statistics


    Item counts issued in 3 years:30(31.91%)
    Items With Fulltext:82(87.23%)

    Download counts of the item
    Download times greater than 0:82(100.00%)
    Download times greater than 100:80(97.56%)
    Total Bitstream Download Counts:26350(0.49%)

    Last Update: 2024-12-01 11:16

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-50 of 94. (2 Page(s) Totally)
    1 2 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2024-09-30 Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521 JCO Global Oncology. 2024 Sep 30;10:Article number e2400125.
    2024-06 Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation Biomedical Journal. 2024 Jun;47(3):Article number 100696.
    2023-09-01 The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study International Journal of Surgery. 2023 Sep 1;109(9):2614-2623.
    2023-06 Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148.
    2023-04 Elevated PD-L1 expression and microsatellite instability in elderly patients with gastric cancer Journal of Immunotherapy. 2023 Apr;46(3):111-119.
    2023-02-05 Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer Cancers. 2023 Feb 5;15(4):Article number 1008.
    2023-02 The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan ESMO Open. 2023 Feb;8(1):Article number 100746.
    2023-01-21 Adjuvant therapy in biliary tract cancers: Oral fluoropyrimidine as a beginning Lancet. 2023 Jan 21-27;401(10372):170-171.
    2023-01 A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer Neoplasia. 2023 Jan;35:Article number 100856.
    2022-12-15 An integrated microfluidic system for cholangiocarcinoma diagnosis from bile by using specific affinity probes Sensors and Actuators B-Chemical. 2022 Dec 15;373:Article number 132724.
    2022-11-01 Revisiting the cerebral hemodynamics of awake, freely moving rats with repeated ketamine self-administration using a miniature photoacoustic imaging system Neurophotonics. 2022 Nov 01;9(4):Article number 045003.
    2022-11 CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer British Journal of Cancer. 2022 Nov;127(9):1615-1628.
    2022-10 The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma Hepatology International. 2022 Oct;16(5):1137-1149.
    2022-10 Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257.
    2022-10 An integrated microfluidic device for automated detection of cancer cells from bile for cholangiocarcinoma prognosis MicroTAS 2022 - 26th International Conference on Miniaturized Systems for Chemistry and Life Sciences. 2022 Oct:229-230.
    2022-09-15 Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin American Journal of Cancer Research. 2022 Sep 15;12(9):4267-4278.
    2022-09 A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study European Journal of Cancer. 2022 Sep;173:123-132.
    2022-07 Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience Annals of Oncology. 2022 Jul;33(Suppl. 6):S535.
    2022-07 A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer Annals of Oncology. 2022 Jul;33(Suppl. 6):S478.
    2022-06-26 The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer Cancers. 2022 Jun 26;14(13):Article number 3137.
    2022-06-22 Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study Frontiers in Oncology. 2022 Jun 22;12:Article number 800842.
    2022-06-16 Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: A prospective cohort study Therapeutic Advances in Medical Oncology. 2022 Jun 16;14:1-13.
    2022-06-02 Transferrin and prealbumin identify esophageal cancer patients with malnutrition and poor prognosis in patients with normal albuminemia: A cohort study Nutrition and Cancer. 2022 Jun 2;74(10):3546-3555.
    2022-06 Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin Journal of Hepato-Biliary-Pancreatic Sciences. 2022 Jun;54(5):607-612.
    2022-06 Comparative genomic analysis and its prognostic impact on survival between viral hepatitis-related and non-viral hepatitis intrahepatic cholangiocarcinoma Journal of Clinical Oncology. 2022 Jun;40(16, Suppl.):Abstract number 4120.
    2022-05-15 Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience American Journal of Cancer Research. 2022 May 15;12(5):2189-2202.
    2022-04-15 The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan American Journal of Cancer Research. 2022 Apr 15;12(4):1884-1898.
    2022-04 A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study British Journal of Cancer. 2022 Apr;126(7):1018-1026.
    2022-02-01 A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550.
    2022-02 Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
    2021-11-20 Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study Therapeutic Advances in Medical Oncology. 2021 Nov 20;Article in Press.
    2021-11-01 Exfoliated tumor cells in bile as a promising indicator of disease status in cholangiocarcinoma Sensors and Actuators B: Chemical. 2021 Nov 01;346:Article number 130526.
    2021-09 A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer Annals of Oncology. 2021 Sep;32(Suppl. 5):S377.
    2021-07-23 AUY922 induces retinal toxicity through attenuating TRPM1 Journal of Biomedical Science. 2021 Jul 23;28:Article number 55.
    2021-07-15 No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol Scientific Reports. 2021 Jul 15;11:Article number 14567.
    2021-06-12 Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
    2021-06-07 In vivo assessment of hypoxia levels in pancreatic tumors using a dual-modality ultrasound/photoacoustic imaging system Micromachines. 2021 Jun 7;12(6):Article number 668.
    2021-05-14 Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma PLoS ONE. 2021 May 14;16(5):Article number e0251811.
    2021-05 TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma Journal of Clinical Oncology. 2021 May;39(15, Suppl.):4143.
    2021-05 A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
    2021-04 Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors Oncologist. 2021 Apr;26(4):e567-e579.
    2021-03-01 Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors Scientific Reports. 2021 Mar 1;11:Article number 4834.
    2021-01-13 Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials Biomolecules. 2021 Jan 13;11(1):Article number 97.
    2020-12-29 Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan PLoS ONE. 2020 Dec 29;15(12):Article number e0244487.
    2020-11-13 The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.] Scientific Reports. 2020 Nov 13;10:Article number 20199.
    2020-11-01 Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients Sensors and Actuators B: Chemical. 2020 Nov 1;322:Article number 128569.
    2020-11 An integrated microfluidic platform for cholangiocarcinoma diagnosis from clinical bile juice samples by utilizing multiple affinity reagents 2020 IEEE 15th International Conference on Nano/Micro Engineered and Molecular System (IEEE Nems 2020). 2020 Nov:261-264.
    2020-10 Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study Liver International. 2020 Oct;40(10):2535-2543.
    2020-10 Psychosocial illness impacts of Taiwanese cancer survivors Quality of Life Research. 2020 Oct;29(Suppl. 1):S91.
    2020-09-22 Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy Radiation Oncology. 2020 Sep 22;15:Article number 221.

    Showing items 1-50 of 94. (2 Page(s) Totally)
    1 2 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback